Discrepancies in response and immune-related adverse events (irAE) of anti-PD-1 monotherapy between races and primary sites in patients (pts) with advanced nonacral cutaneous melanoma (NACM) Meeting Abstract


Authors: Bai, X.; Shoushtari, A. N.; Warner, A. B.; Quach, H.; Cann, C. G.; Zhang, M.; Pallan, L.; Harvey, C.; Si, L.; Tang, B.; Cui, C.; Kim, M. S.; Sharova, T.; Flaherty, K.; Long, G. V.; Menzies, A. M.; Sullivan, R. J.; Boland, G. M.; Johnson, D. B.; Guo, J.; MGH Melanoma Clinical Research Team
Abstract Title: Discrepancies in response and immune-related adverse events (irAE) of anti-PD-1 monotherapy between races and primary sites in patients (pts) with advanced nonacral cutaneous melanoma (NACM)
Meeting Title: 2021 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 15 Suppl.
Meeting Dates: 2021 Jun 4-8
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-05-20
Language: English
ACCESSION: WOS:000708120605132
DOI: 10.1200/JCO.2021.39.15_suppl.9530
PROVIDER: wos
Notes: Meeting Abstract: 9530 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors